Discovery of novel acridine based inhibitors of Bruton's tyrosine kinase (BTK) via pharmacophore modeling and machine learning-driven virtual screening followed by molecular dynamic studies. [PDF]
J Comput Aided Mol DesShahin R +6 more
europepmc +1 more source
Emerging IgE and non-IgE targeted therapies for chronic urticaria. [PDF]
Ann Allergy Asthma ImmunolChhiba KD, Saini SS.
europepmc +1 more source
A review of Bruton's tyrosine kinase inhibitors in multiple sclerosis. [PDF]
Ther Adv Neurol DisordAiras L +8 more
europepmc +1 more source
Targeting immune dysregulation in chronic spontaneous urticaria: beyond antihistamines. [PDF]
Korean J Intern MedYe YM.
europepmc +1 more source
Bruton's Tyrosine Kinase (BTK) Mutations in Chronic Lymphocytic Leukemia (CLL): A Clinical View. [PDF]
Mediterr J Hematol Infect DisMolica S, Allsup D.
europepmc +1 more source
Multiple sclerosis: 2026 update. [PDF]
Free NeuropatholKlotz L, Wattjes MP, Kuhlmann T.
europepmc +1 more source
Efficacy and safety study of targeted small-molecule drugs in the treatment of systemic lupus erythematosus. [PDF]
Arthritis Res TherWang S, Ning W, Tang H, Mu C, Huang X.
europepmc +1 more source
Targeting of kinases to treat neurodegenerative diseases. [PDF]
Pharmacol RevShomali T, Trempe JF.
europepmc +1 more source
Targeting Bruton's tyrosine kinase (BTK) as a signaling pathway in immune-mediated diseases: from molecular mechanisms to leading treatments. [PDF]
Adv RheumatolTavakoli GM, Yazdanpanah N, Rezaei N.
europepmc +1 more source